SNOA   $2.6  -2.26% Market Closed

Sonoma Pharmaceuticals Inc
Total Cash 2.59M
totalCashPerShare 2.704
EBITDA -4.46M
Total Debt 420.00K
quickRatio 1.619
currentRatio 3.18
Total Revenue 12.70M
debtToEquity 8.442
Revenue/Share 20.967
ROA -0.19591999
ROE -0.7465
grossProfits
freeCashflow -1.70M
operatingCashflow -3.10M
earningsGrowth
revenueGrowth -0.011
grossMargins 0.38167998
ebitdaMargins -0.35152
operatingMargins -0.34592
profitMargins -0.35908002
enterpriseValue 550.21K
forwardPE -1.5888889
floatShares 942.50K
sharesOutstanding 1.34M
sharesShort 79.90K
sharesShortPriorMonth 42.68K
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.02%
Short Ratio help_outline 0.22%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 5.236
Price To Book help_outline 0.55
earningsQuarterlyGrowth
netIncomeToCommon -4.56M
trailingEps -6.20%
forwardEps -1.80%
enterpriseToEbitda -0.12
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.0 3Q 2024
institutionsCount 19
lastUpdated Nov. 7, 2024, 2:33 a.m.